실시간
FierceBiotechWith ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity raceFierceBiotechThe new standard for trusted AI in biopharmaEndpoints NewsPost-Hoc Live: How much is everyone in biopharma getting paid?BioWorldAppointments and advancements for June 9, 2026BioWorldFinancings for June 9, 2026BioWorldIn the clinic for June 9, 2026BioWorldOther news to note for June 9, 2026BioWorldRegulatory actions for June 9, 2026Endpoints NewsWuXi AppTec added to Pentagon list of companies linked to Chinese militaryMerck & Co.Merck and Gilead discontinue Phase III KEYNOTE-D46/EVOKE-03 study - The Pharma LetterFierceBiotechBial bails after Parkinson’s fail, axing asset over phase 2 missMerck & Co.Major US Pharma and Biotech Deals of the Past Decade - Global Banking & Finance Review
eLife 2026년 1월 29일

Retraction: PAK3 downregulation induces cognitive impairment following cranial irradiation

Retraction: PAK3 downregulation induces cognitive impairment following cranial irradiation

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.